133 related articles for article (PubMed ID: 12181096)
1. [Effect of interleukin I receptor antigonist gene therapy on arthritis induced by type II collagen in mice].
Yang G; Di C; Jiang M; Li F; Zhang Y; Yuan L; Song Q; Ma D
Zhonghua Yi Xue Za Zhi; 2002 Jul; 82(14):990-4. PubMed ID: 12181096
[TBL] [Abstract][Full Text] [Related]
2. Electrotransfer of human IL-1Ra into skeletal muscles reduces the incidence of murine collagen-induced arthritis.
Jeong JG; Kim JM; Ho SH; Hahn W; Yu SS; Kim S
J Gene Med; 2004 Oct; 6(10):1125-33. PubMed ID: 15452879
[TBL] [Abstract][Full Text] [Related]
3. Protection against collagen-induced arthritis by intramuscular gene therapy with an expression plasmid for the interleukin-1 receptor antagonist.
Kim JM; Jeong JG; Ho SH; Hahn W; Park EJ; Kim S; Yu SS; Lee YW; Kim S
Gene Ther; 2003 Sep; 10(18):1543-50. PubMed ID: 12907945
[TBL] [Abstract][Full Text] [Related]
4. C3-Tat/HIV-regulated intraarticular human interleukin-1 receptor antagonist gene therapy results in efficient inhibition of collagen-induced arthritis superior to cytomegalovirus-regulated expression of the same transgene.
Bakker AC; van de Loo FA; Joosten LA; Arntz OJ; Varley AW; Munford RS; van den Berg WB
Arthritis Rheum; 2002 Jun; 46(6):1661-70. PubMed ID: 12115199
[TBL] [Abstract][Full Text] [Related]
5. Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis.
Gabay C; Marinova-Mutafchieva L; Williams RO; Gigley JP; Butler DM; Feldmann M; Arend WP
Arthritis Rheum; 2001 Feb; 44(2):451-62. PubMed ID: 11229477
[TBL] [Abstract][Full Text] [Related]
6. [Construction and expression of eukaryotic expression vector pBK-IL-1ra].
Yang G; Li F; Jiang M; Di C; Huang J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Aug; 22(4):332-5. PubMed ID: 12903444
[TBL] [Abstract][Full Text] [Related]
7. Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
Hur W; Cho ML; Yoon SK; Kim SY; Ju JH; Jhun JY; Heo SB; Moon YM; Min SY; Park SH; Kim HY
Immunol Lett; 2006 Aug; 106(2):154-62. PubMed ID: 16793145
[TBL] [Abstract][Full Text] [Related]
8. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
Zhou F; He X; Iwakura Y; Horai R; Stuart JM
Arthritis Rheum; 2005 Dec; 52(12):3731-8. PubMed ID: 16320323
[TBL] [Abstract][Full Text] [Related]
9. Electro-gene therapy of collagen-induced arthritis by using an expression plasmid for the soluble p75 tumor necrosis factor receptor-Fc fusion protein.
Kim JM; Ho SH; Hahn W; Jeong JG; Park EJ; Lee HJ; Yu SS; Lee CS; Lee YW; Kim S
Gene Ther; 2003 Aug; 10(15):1216-24. PubMed ID: 12858186
[TBL] [Abstract][Full Text] [Related]
10. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
[TBL] [Abstract][Full Text] [Related]
11. Immune modulation of collagen-induced arthritis by intranasal cytokine gene delivery: a model for the therapy of rheumatoid arthritis.
Woods AM; Thompson SJ; Wooley PH; Panayi G; Klavinskis LS
Arthritis Rheum; 2005 Dec; 52(12):3761-71. PubMed ID: 16329091
[TBL] [Abstract][Full Text] [Related]
12. Plasmid encoding interleukin-4 in the amelioration of murine collagen-induced arthritis.
Kageyama Y; Koide Y; Uchijima M; Nagata T; Yoshida A; Taiki A; Miura T; Nagafusa T; Nagano A
Arthritis Rheum; 2004 Mar; 50(3):968-75. PubMed ID: 15022341
[TBL] [Abstract][Full Text] [Related]
13. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
[TBL] [Abstract][Full Text] [Related]
14. [Suppression of articular cartilage breakdown in osteoarthritis by interleukin-1 receptor antagonist using ex vivo gene therapy].
Guo WS; Ma L; Li ZR
Zhonghua Yi Xue Za Zhi; 2004 May; 84(10):853-6. PubMed ID: 15200893
[TBL] [Abstract][Full Text] [Related]
15. Anti-type II collagen antibody accelerates arthritis via CXCR2-expressing cells in IL-1 receptor antagonist-deficient mice.
Kagari T; Tanaka D; Doi H; Iwakura Y; Shimozato T
Eur J Immunol; 2007 Oct; 37(10):2753-63. PubMed ID: 17823985
[TBL] [Abstract][Full Text] [Related]
16. Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist.
Pan RY; Chen SL; Xiao X; Liu DW; Peng HJ; Tsao YP
Arthritis Rheum; 2000 Feb; 43(2):289-97. PubMed ID: 10693868
[TBL] [Abstract][Full Text] [Related]
17. [Construction and identification of recombinant retroviral vector containing human interleukin 1 receptor antagonist and its expression in osteoarthritic human articular chondrocytes].
Rui Y; Wang Y; Zhang X; Sun H; Qu Z; Dai K
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 May; 22(5):533-8. PubMed ID: 18630429
[TBL] [Abstract][Full Text] [Related]
18. Local expression of interleukin-1 receptor antagonist by plasmid DNA improves mortality and decreases myocardial inflammation in experimental coxsackieviral myocarditis.
Lim BK; Choe SC; Shin JO; Ho SH; Kim JM; Yu SS; Kim S; Jeon ES
Circulation; 2002 Mar; 105(11):1278-81. PubMed ID: 11901035
[TBL] [Abstract][Full Text] [Related]
19. Immunoregulatory effects of allogeneic mixed chimerism induced by nonmyeloablative bone marrow transplantation on chronic inflammatory arthritis and autoimmunity in interleukin-1 receptor antagonist-deficient mice.
Cho SG; Min SY; Park MJ; Lee KW; Cho YG; Cho ML; Chang HS; Park SH; Lee JW; Min WS; Kim CC; Kim HY
Arthritis Rheum; 2006 Jun; 54(6):1878-87. PubMed ID: 16736524
[TBL] [Abstract][Full Text] [Related]
20. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
